Newsroom

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Atkore Inc. (NYSE: ATKR) to Prysmian S.p.A. for $95.00 per share in cash.Halper Sadeh encourages Atkore shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Atkore and its board of directors violated the federal secu...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Luxfer Holdings PLC (NYSE: LXFR) to affiliates of Wynnchurch Capital, L.P. for $17.37 per ordinary share in cash.Halper Sadeh encourages Luxfer shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Luxfer and its boar...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Northrim BanCorp, Inc. (NASDAQ: NRIM) and PBCO Financial Corporation.Halper Sadeh encourages Northrim shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Northrim and its board of directors violated the federal se...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc. (NASDAQ: BLFS) to Repligen Corporation for $11.25 per share in cash and 0.1442 shares of Repligen common stock.Halper Sadeh encourages BioLife shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whet...

LOS ANGELES--(BUSINESS WIRE)--XTIA CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against XTI Aerospace, Inc....

NEW YORK--(BUSINESS WIRE)--Destiny Tech100 Inc. (NYSE: DXYZ) today announced financial results for the quarter ended June 30, 2026. The fund reported a net asset value (NAV) of $34.30 per share of common stock, up from $24.56 per share at the end of the first quarter of 2026.As of June 30, 2026, Destiny Tech100’s investment portfolio had an aggregate fair value of approximately $1.64 billion, including short-term investments. The fund maintains positions in a variety of privately-held technology...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Noalan v. XTI Aerospace, Inc. et al., Case No. 26-cv-07378, on behalf of persons and entities that purchased or otherwise acquired XTI Aerospace, Inc. (“XTI Aerospace” or the “Company”) (NASDAQ: XTIA) securities between April 15, 2026 and August 17, 2026, inclusive (the “Class Period”)...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Labed v. Innventure, Inc. et al., Case No. 26-cv-07377, on behalf of persons and entities that purchased or otherwise acquired Innventure, Inc. (“Innventure” or the “Company”) (NASDAQ: INV) securities between November 17, 2025 and August 13, 2026, inclusive (the “Class Period”). Plaint...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total...

TOKYO--(BUSINESS WIRE)--Rigaku Corporation, filiale de Rigaku Holdings et un partenaire mondial spécialisé dans les solutions pour systèmes d’analyse par rayons X (siège social : Akishima, Tokyo ; PDG : Jun Kawakami ; ci-après « Rigaku »), et l’Université de Tohoku (Sendai, préfecture de Miyagi ; président : Teiji Tominaga ; ci-après « l’Université de Tohoku ») ont créé, le 1er août 2026, le Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology : Beyond The Limits (ci-aprè...